Advertisement

Index by author

May 01, 1987; Volume 241,Issue 2

  1. Cappelli-bigazzi, M

    1. Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion.
      M Chiariello, G Ambrosio, M Cappelli-Bigazzi, E Nevola, P Perrone-Filardi, G Marone and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 560-568;

  2. Carter, C

    1. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat.
      T Dennis, R L'Heureux, C Carter and B Scatton
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 642-649;

  3. Cash, W D

    1. Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
      M Williams, J Francis, G Ghai, A Braunwalder, S Psychoyos, G A Stone and W D Cash
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 415-420;

  4. Cerletti, C

    1. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
      M Hatmi, A del Maschio, J Lefort, G de gaetano, B B Vargaftig and C Cerletti
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 623-627;

  5. Cherry, P D

    1. Evidence for the role of endothelium-derived relaxing factor in acetylcholine-induced vasodilatation in the intact lung.
      P D Cherry and C N Gillis
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 516-520;

  6. Chiariello, M

    1. Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion.
      M Chiariello, G Ambrosio, M Cappelli-Bigazzi, E Nevola, P Perrone-Filardi, G Marone and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 560-568;

  7. Chrousos, G P

    1. Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU 486 in man.
      S Kawai, L K Nieman, D D Brandon, R Udelsman, D L Loriaux and G P Chrousos
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 401-406;

  8. Cohen, M L

    1. Interaction of 5-hydroxykynurenamine, L-kynurenine and kynuramine with multiple serotonin receptors in smooth muscle.
      D W Pomfret, K W Schenck, P Fludzinski and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 465-471;

  9. Condorelli, M

    1. Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion.
      M Chiariello, G Ambrosio, M Cappelli-Bigazzi, E Nevola, P Perrone-Filardi, G Marone and M Condorelli
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 560-568;

  10. Cooke, J P

    1. Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs.
      N A Flavahan, J P Cooke, J T Shepherd and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics May 1987, 241 (2) 361-365;
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement